Navigation Links
ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical
Date:8/31/2011

or many years, and having assessed the advantages of his materials relative to other marketed technologies, I am enthusiastic about the new roads we are taking together to overcome important problems in orthopedic and other surgical specialties."  

ORTHOCON recently initiated development programs to advance the Bezwada technology towards commercialization.  

About Bezwada Biomedical

Bezwada Biomedical, established in 2003, is focused on novel and biocompatible materials applicable to unmet medical and surgical needs. The company, with specialized laboratory and manufacturing facilities in Hyderabad, India and Hillsborough, New Jersey, develops and produces novel polymers and precursors at experimental and commercial scales. For more information, please visit www.bezwadabiomedical.com.

About ORTHOCON

Founded in 2005, ORTHOCON develops, manufactures, markets, and sells products that stop bone bleeding. In 2011, ORTHOCON announced the commercial introduction of its first 510(k) cleared product, Hemasorb Absorbable Bone Hemostat Matrix, and the 510(k) clearance of Hemasorb Apply, a proprietary applicator designed to deliver Hemasorb and other ORTHOCON products presently under development.  

ORTHOCON is funded by leading international venture capital investment firms. The company occupies 8,000 square feet at its state-of-the-art facility in Irvington, New York. For more information, please visit www.orthocon.com .


'/>"/>
SOURCE ORTHOCON, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ORTHOCON®, Inc. Receives 510(k) Clearance to Market HEMASORB Apply™
2. ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB®
3. ORTHOCON® Announces U.S. Market Launch of HEMASORB®
4. Caliper Life Sciences Announces IVIS Spectrum CT
5. Auxilium Pharmaceuticals Announces Investor Event to Occur at 2011 ASSH Meeting on September 9, 2011
6. BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences
7. Elbit Imaging Announces Availability of Investor Relations Presentation - Analysis Sources and Uses
8. Elbit Imaging Ltd. Announces Second Quarter Results for 2011
9. Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011
10. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
11. Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Levi & Korsinsky is investigating the Board of ... BIIB) for possible violations of federal securities laws. The ... and/or directors have violated Sections 10(b) and 20(a) of ... 24, 2015, prior to the opening of the market, ... other things, the Company lowered its prior revenue guidance ...
(Date:8/4/2015)... Inc. (Nasdaq: ISIS ) today reported net income ... and six months ended June 30, 2015, respectively, compared ... million for the same periods in 2014. Isis, significantly ... than $90 million of revenue Isis earned in the ... to license  ISIS-FXI Rx .  Isis increased its cash ...
(Date:8/4/2015)... FLORHAM PARK, N.J. , Aug. 4, ... partnered with University of Massachusetts Medical School,s ... enhancements and support regarding clinical protocols and ... Workflow Platform. Specialty medication ... ArmadaOne and helps to ensure optimal patient ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 2Armada Health Care collaborates with University of Massachusetts Medical School for ArmadaOne Specialty Pharmacy Platform 3
... SILVER SPRING, Md. , May 26 The U.S. Food and ... of severe liver injury in patients taking the weight-loss medication orlistat, marketed as ... , (Logo:   ... The FDA has ...
... May 26 CANTEL MEDICAL CORP. (NYSE: ... CEO, will be presenting at the Jefferies 2010 Global Life Sciences Conference. ... Wednesday, June 9, 2010 at The Grand Hyatt Hotel in ... following the presentation. In addition, Mr. Krakauer and Seth R. Segel ...
Cached Medicine Technology:FDA: Rare Cases of Liver Injury Reported With Use of Xenical, Alli 2FDA: Rare Cases of Liver Injury Reported With Use of Xenical, Alli 3Cantel Medical Corp. to Present at the Jefferies 2010 Global Life Sciences Conference 2
(Date:8/4/2015)... ... 2015 , ... NOVA Pride , Northern Virginia’s largest and newest LGBTQ ... identify, to join them in paving “The Road Ahead” at the second annual Northern ... October 3, 2015, from 12-9pm. In order to ensure the success of this important ...
(Date:8/4/2015)... ... 05, 2015 , ... The Journal of Pain Research has published ... author Professor Akiko Okifuji says “Both obesity and chronic pain are serious public health ... that one causes the other. Rather, there appear to be multiple factors that contribute ...
(Date:8/4/2015)... ... 04, 2015 , ... Exsurco Medical, Inc. is ... (AATB) as an Affiliate Member. Exsurco Medical finds this an exciting opportunity ... improve lives by promoting the safety, quality and availability of donated tissue for ...
(Date:8/4/2015)... WASHINGTON, D.C. (PRWEB) , ... August 04, 2015 ... ... issues fellowship focused on sexual and reproductive health and rights in Indonesia for ... Journalists will visit a number of sites in Indonesia and attend the International ...
(Date:8/4/2015)... ... August 04, 2015 , ... Healthy Origins® Cognizin® Citicoline ... a trademark for Citicoline, a nutrient that supports memory function and healthly cognition.* ... have more of a semi-solid composition. Vegetarian capsules are also natural, non-toxic ...
Breaking Medicine News(10 mins):Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 4Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3
... (Jan. 7, 2010) In the Old West, camps ... or strategy. Likewise, two important signaling molecules communicate across ... from the UT Health Science Center San Antonio reported ... for potential future treatment of epilepsy, stroke and other ...
... Reporter , FRIDAY, Jan. 7 (HealthDay News) -- When you think ... new research finds that skin isn,t the only thing that ages. ... and recede, making you look even older. And if crow,s ... socket gradually widen, the brow bone recedes and the jawbone becomes ...
... The interplay between a major tumor-suppressing gene, a truncated ... basis for explaining the less aggressive form of chronic ... in the Jan. 4 edition of the Journal ... could reveal new mechanisms of resistance to chemotherapy among ...
... By Kathleen Doheny HealthDay Reporter , FRIDAY, ... treat their breast cancer patients -- and whether those ... larger role in whether a cancer returns than experts ... 994 women with ductal carcinoma in situ, the most ...
... -- Researchers have found that brain cells need to ... physically close together, in order to ensure successful brain-wide ... between the right and left sides of the brain ... and sound. Previous research has shown that changes in ...
... Ont., January 7, 2011 People suffering from fatty liver ... stroke than individuals without fatty liver, according to a study ... Sciences Centre. The study is the first to find a ... by the accumulation of fat in the liver in non ...
Cached Medicine News:Health News:Age Takes Toll on Facial Bones, Study Finds 2Health News:Age Takes Toll on Facial Bones, Study Finds 3Health News:MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia 2Health News:MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia 3Health News:Breast Cancer Outcome: Your Doctor Matters 2Health News:Healthy Brain Development May Be a Matter of Timing 2
... The CELL-DYN 3200 sets a benchmark ... light scatter for WBC, RBC, PLT ... meets the needs of today's laboratory. ... five-part differential analysis, automated sample handling, ...
... Test is a color immunochromatographic assay using ... labeled color particles coated at two separate ... greater sensitivity than the conventional single label ... procedure, a throat swab is subjected to ...
... Fertell test is an easy to use, one ... reserve by means of determining the amount of ... sample. The test is performed two days after ... menstrual cycle) and is similar in design and ...
... The Cholestech GDX System delivers an unmatched ... the ideal solution for assessing and monitoring a ... product demo, click here ., ,The CLIA-waived ... delivers A1C results in less than 5 minutes. ...
Medicine Products: